EUVIMEDEUVIMED entdecken
Open Access

Tumor Cell Count and Total Cell Count as Surrogate Indicators of Comprehensive Genomic Profiling Success in Pancreatic Cancer Specimens Collected by Endoscopic Ultrasonography‐Guided Tissue Acquisition

Go Ikeda iD, Susumu Hijioka iD, Yuka Takahashi, Yoshikuni Nagashio, Shota Harai, Daiki Yamashige iD, Yasuhiro Komori, Atsushi Horiike, Takuji Okusaka, Nobuyoshi Hiraoka

Journal of Hepato-Biliary-Pancreatic Sciences · 2026-07 · 33 (7) · 576-583

DOI: 10.1002/jhbp.70106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, online erschienen am 31.03.2026. Verfasst von Go Ikeda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Endosonography, Gene Expression Profiling. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science, Sysmex Corporation, National Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

We aimed to establish the tumor cell count and total cell count as surrogate criteria on the basis of the tissue area of biopsy specimen by endoscopic ultrasound‐guided tissue acquisition (EUS‐TA) for comprehensive genomic profiling (CGP) in pancreatic cancer.

Methods

Samples from 114 patients with unresectable pancreatic ductal adenocarcinoma were analyzed. Tumor cells were visually counted, and total cells were quantified with imaging software. Receiver operating characteristic curves determined optimal cutoffs for achieving DNA yield ≥ 200 ng using the OncoGuide NCC Oncopanel.

Results

Thresholds of 2300 tumor cells (AUC 0.653, 95% CI 0.552–0.750) and 5923 total cells (AUC 0.671, 95% CI 0.565–0.778) were identified. For ≥ 2300 tumor cells, sensitivity was 48.7% and specificity 91.2%, with a positive predictive value (PPV) of 92.9%. For ≥ 5923 total cells, sensitivity was 52.5% and specificity 82.4%, with a PPV of 87.5%. A clinically practical threshold of 6000 total cells yielded a sensitivity of 48.8%, a specificity of 82.4%, and a PPV of 86.7%.

Conclusion

Tumor cell counts ≥ 2300 and total cell counts ≥ 6000 may serve as surrogate criteria for tissue area to determine EUS‐TA specimen suitability for CGP in pancreatic cancer. Given that tumor cell count is a more biologically relevant indicator, total cell count should be used as a supplementary indicator.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalEndosonographyGene Expression ProfilingHumansFemaleMaleCell CountAgedMiddle AgedSensitivity and SpecificityPredictive Value of TestsROC CurveEndoscopic Ultrasound-Guided Fine Needle AspirationAged, 80 and over

Stichwörter der Autor:innen

comprehensive genomic profilingendoscopic ultrasound‐guided tissue acquisitionpancreatic cancertotal cell counttumor cell count

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan.
  • Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
  • Division of Innovative Pathology and Laboratory Medicine, National Cancer Center EPOC, Tokyo, Japan.
  • Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan.

ORCID-Profile: Go Ikeda, Susumu Hijioka, Daiki Yamashige

Förderung

  • Japan Society for the Promotion of Science
  • Sysmex Corporation
  • National Cancer Center

Zitieren

APA

Ikeda, G., Hijioka, S., Takahashi, Y., Nagashio, Y., Harai, S., Yamashige, D., Komori, Y., Horiike, A., Okusaka, T., & Hiraoka, N. (2026). Tumor Cell Count and Total Cell Count as Surrogate Indicators of Comprehensive Genomic Profiling Success in Pancreatic Cancer Specimens Collected by Endoscopic Ultrasonography‐Guided Tissue Acquisition. Journal of Hepato-Biliary-Pancreatic Sciences, 33(7), 576-583. https://doi.org/10.1002/jhbp.70106

Vancouver

Ikeda G, Hijioka S, Takahashi Y, Nagashio Y, Harai S, Yamashige D, et al. Tumor Cell Count and Total Cell Count as Surrogate Indicators of Comprehensive Genomic Profiling Success in Pancreatic Cancer Specimens Collected by Endoscopic Ultrasonography‐Guided Tissue Acquisition. Journal of Hepato-Biliary-Pancreatic Sciences. 2026;33(7):576-583. doi:10.1002/jhbp.70106

BibTeX
@article{Ikeda2026,
  author = {Ikeda, Go and Hijioka, Susumu and Takahashi, Yuka and Nagashio, Yoshikuni and Harai, Shota and Yamashige, Daiki and Komori, Yasuhiro and Horiike, Atsushi and Okusaka, Takuji and Hiraoka, Nobuyoshi},
  title = {Tumor Cell Count and Total Cell Count as Surrogate Indicators of Comprehensive Genomic Profiling Success in Pancreatic Cancer Specimens Collected by Endoscopic Ultrasonography‐Guided Tissue Acquisition},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2026},
  volume = {33},
  number = {7},
  pages = {576--583},
  doi = {10.1002/jhbp.70106}
}
Kostenlos starten →